April 9 (Reuters) - Swiss drugmaker Novartis AG will buy U.S. gene therapy company AveXis Inc for $8.7 billion in cash, the companies said on Monday.


90
Thanks for voting


Reuters

16 Related Articles, between 2018-02-16 and 2018-03-28